ProfileGDS4459 / ENSG00000163803
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 31% 50% 34% 32% 32% 31% 35% 34% 34% 34% 27% 32% 31% 28% 34% 49% 20% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.831
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.3950
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 33.734
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.9132
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 53.7132
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 63.731
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 73.835
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.7134
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 93.7134
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 103.7634
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.4827
GSM623475group B, liver allograft wedge biopsie placebo treatment 23.6132
GSM623476group B, liver allograft wedge biopsie placebo treatment 33.6531
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.7228
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.7134
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.3749
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.3720